Kwin克胜品牌怎么样 申请店铺

我要投票 Kwin克胜在农药杀虫剂行业中的票数:624 更新时间:2026-01-24
Kwin克胜是哪个国家的品牌?「Kwin克胜」是 江苏克胜集团股份有限公司 旗下著名品牌。该品牌发源于江苏,由创始人吴重言在1993期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力Kwin克胜品牌出海!将品牌入驻外推网,定制Kwin克胜品牌推广信息,可以显著提高Kwin克胜产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

Kwin克胜怎么样

江苏克胜集团是一家集科研、制造、国际国内市场一体化的以植物保护、生物医药、房地产、农村金融、五星级酒店为主体的涵盖五大产业的国家重点高新技术企业。

克胜股份公司主要从事农化产品的科技研发、绿色制造、营销服务及国际贸易等,具备年产销农药2万吨原药和各类先进环保剂型的能力,产品适用于各种农作物。多年来,公司坚持科技先导、规模发展、名牌兴市,取得骄人业绩。集团在国内同行中率先一次性通过ISO9001质量管理体系和ISO14001环境管理体系"双认证",现已跻身"国家重点高新技术企业、中国驰名商标企业、中国名牌产品企业、全国化工行业先进企业、全国守合同重信用企业、全国质量管理先进企业"行列,还获得江苏省"五一劳动奖状"、"质量管理奖",是省级优秀企业、环保先进企业、清洁文明生产企业、外贸先进企业、信贷诚信企业、企业文化先进单位,成为全国农化行业领军企业。

克胜药业是克胜集团实施资本运作,进军医药保健领域的大手笔。依托品牌影响力,药业顺利通过GMP认证,建成省级企业技术中心,成为中国生物化学制药协会常务理事单位。突出发展眼科药,带动骨科药、肝胆科药和消化科药,建成以生物制药为主,中西药并举的国家中型制药企业。自主研

发的中成药驸马开痹片和全国首创的生物制药硫酸软骨素滴眼液,倍受市场亲睐,打出了克胜药业品牌,被誉为中国医药界的后起之秀。公司还承担了硫酸软骨素滴眼液、复方硫酸软骨素片标准的制定工作。

克胜长期与中国科学院、华东理工大学、郑州大学、江苏省农科院、江苏省农药研究所、西北农林科技大学等20多家科研院所、高等院校进行合作,投入1600万元,在南京创办技术中心。

克胜先后承担国家级星火计划、“双加”工程、农药专项等十多个,成功开发了一批替代高毒农药,满足农业生产需要的新产品。其中既有填补国内市场空白的新型杀螨剂,又有国内首家生产的新型杀虫剂,还有水乳剂、微乳剂、悬浮剂、颗粒剂、水分散粒剂等一批新剂型。

Jiangsu Kesheng group is a national key high-tech enterprise integrating scientific research, manufacturing and international and domestic markets, with plant protection, biomedicine, real estate, rural finance and five-star hotel as the main body, covering five industries. Kesheng Co., Ltd. is mainly engaged in scientific and technological research and development, green manufacturing, marketing services and international trade of agricultural chemical products. It has the ability to produce and sell 20000 tons of pesticides and all kinds of advanced environmental protection dosage forms every year. Its products are suitable for all kinds of crops. Over the years, the company adheres to science and technology leading, scale development, famous brand prosperity, and has achieved remarkable achievements. The group has taken the lead in passing the "double certification" of ISO9001 quality management system and ISO14001 environmental management system in one time among its domestic counterparts, and now it has become one of the "national key high-tech enterprises, Chinese well-known trademark enterprises, Chinese famous brand product enterprises, national advanced chemical industry enterprises, national contract abiding and trustworthy enterprises, and national advanced quality management enterprises". It has also won the "May 1st Labor" of Jiangsu Province The "dynamic Award" and "quality management award" are provincial excellent enterprises, advanced environmental protection enterprises, clean and civilized production enterprises, advanced foreign trade enterprises, credit and integrity enterprises, and advanced enterprises in corporate culture. They have become the leading enterprises in the national agrochemical industry. Kesheng Pharmaceutical Co., Ltd. is the capital operation of Kesheng group, which is a big hand in the field of medical and health care. Relying on the brand influence, the pharmaceutical industry has successfully passed GMP certification, established a provincial enterprise technology center, and become the executive director unit of China Biochemical Pharmaceutical Association. We will give priority to the development of ophthalmic drugs, promote orthopedic drugs, hepatobiliary drugs, and digestive drugs, and build a national medium-sized pharmaceutical enterprise that focuses on biopharmaceuticals and develops both Chinese and Western medicines. Fuma kaibi tablet, a Chinese patent medicine independently developed, and chondroitin sulfate eye drops, a national first biopharmaceutical drug, are highly favored by the market, making Kesheng pharmaceutical brand, known as the rising star of the Chinese pharmaceutical industry. The company has also undertaken the formulation of standards for chondroitin sulfate eye drops and compound chondroitin sulfate tablets. Kesheng has long cooperated with more than 20 scientific research institutes and institutions of higher learning, including Chinese Academy of Sciences, East China University of science and technology, Zhengzhou University, Jiangsu Academy of Agricultural Sciences, Jiangsu Pesticide Research Institute, Northwest University of agriculture and forestry science and technology, and invested 16 million yuan to establish a technology center in Nanjing. Kesheng has successively undertaken more than ten national Spark Program, double addition project and pesticide project, and successfully developed a batch of new products to replace high toxic pesticides and meet the needs of agricultural production. Among them, there are not only new acaricides to fill the gaps in the domestic market, but also new insecticides first produced in China, as well as a number of new dosage forms such as water emulsion, microemulsion, suspension agent, granule and water dispersing granule.

本文链接: https://brand.waitui.com/764ab5731.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

美股大型科技股盘前涨跌不一,Arm涨超2%

36氪获悉,美股大型科技股盘前涨跌不一,截至发稿,Arm涨超2%,英伟达涨超1%,谷歌涨0.1%,微软涨0.06%;特斯拉跌0.17%,奈飞跌0.11%,亚马逊跌0.07%,苹果跌0.03%。

29分钟前

热门中概股美股盘前涨跌互现,阿里巴巴跌超1%

36氪获悉,热门中概股美股盘前涨跌互现,截至发稿,阿里巴巴、京东跌超1%,小鹏汽车跌近1%,网易跌0.48%,蔚来跌0.21%;百度涨超1%,拼多多涨0.75%,理想汽车涨0.42%,B站涨0.09%。

29分钟前

晶升股份:拟购买为准智能100%股份,交易作价8.57亿元

36氪获悉,晶升股份公告,公司拟通过发行股份及支付现金的方式购买本尚科技等10名交易对方持有的为准智能100%股份,同时募集配套资金。为准智能100%股份的交易作价为8.57亿元。本次交易构成关联交易和重大资产重组,但不构成重组上市。交易完成后,为准智能将成为上市公司控股子公司。

29分钟前

天合光能:将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”

36氪获悉,天合光能公告,公司拟缩减“年产35GW直拉单晶项目”的募集资金投资金额,不再实施二期15GW项目,并将剩余募集资金17亿元用于新项目“分布式智慧光伏电站建设项目”。新项目预计2026年底建成并投入运营。公司表示,本次变更有利于提高募集资金使用效率,合理优化资源配置,巩固市场地位,不会对公司正常经营产生不利影响。该事项尚需提交公司股东会和债券持有人会议审议通过后方可实施。

29分钟前

宝洁第二财季净销售额222亿美元,同比增长1%

当地时间1月22日,宝洁公司发布2026财年第二季度(2025年10-12月)财报。财报显示,第二财季净销售额为222亿美元,同比增长1%;摊薄后每股净收益为1.78美元,同比下降5%。该公司维持2026财年总销售额同比增长1%至5%的指引区间,将2026财年摊薄后每股净收益增长指引从原先的3%-9%调整至1%-6%。(界面)

29分钟前

本页详细列出关于Kwin克胜的品牌信息,含品牌所属公司介绍,Kwin克胜所处行业的品牌地位及优势。
咨询